LMBP plasmid details

Last data update: 15 January 2021 04:14 CET

Plasmid name: p1168hIL6mCRE-luc+ (LMBP 4499)

Add to cart

New search

Price category: Cat. 1 (cf. price list)
Status: GeneCorner core plasmid
GeneCorner sequence: (View with Genome Compiler)
analysis results


Cloned DNA: Photinus pyralis (firefly) luciferase gene (LUC); mutated coding region (LUCm; luc(+))
Promoter: Human interleukin 6 promoter (IL6); mutated sequence
binding site:
Terminator: Simian virus 40 polyadenylation signal (SV40 polyA)
Synthetic polyadenylation signal (polyA)
Selection marker: Ampicillin (amp)
Replicon: Escherichia coli plasmid pMB1 origin
Phage f1 origin
Host range: Escherichia coli
Mammalian cells
Parental clone: pGL3-Basic; pMahIL6P
Further information: The plasmid was constructed by inserting the XmaI/HindIII fragment of pMahIL6P, containing the human IL6 promoter, between the XmaI and HindIII sites of pGL3-Basic.
The binding site for the cyclic AMP-responsive element-binding protein (CRE) transcription factor of the human IL6 promoter was abolished by site-directed mutagenesis, creating an additional BamHI site.
The SalI site between the SV40 polyA and the pMB1 origin was filled in. However, the resulting PvuI site could not be experimentally confirmed.
Mammalian cells can be directly transfected transiently with the plasmid. However, promoter regulation can be better evaluated when the mammalian cells are stably transfected.
The nucleotide sequence of this plasmid corresponds with the EMBL Nucleotide Sequence Database accession number LT727234.1.
The nucleotide sequence of the genomic human IL6 DNA corresponds with the EMBL Nucleotide Sequence Database accession number AC073072.11, except for the C nucleotide at promoter position -174 (polymorphism mutant) which was changed into a G nucleotide (wild type).
Other name of the plasmid is p1168huIL6Pluc+CRE(BamHI)mut*.
EMBL Accession number: AC073072.11, view at EMBL, GenBank, DDBJ
LT727234.1, view at EMBL, GenBank, DDBJ
Latest sequence update: 29/04/2004
Sequence detail:
Mutator oligonucleotide used:                

             CRE mutant          
Authenticity test: Restriction enzyme pattern analysed at GeneCorner: BamHI, BglI/SphI, HindIII, NcoI/SalI, PvuI and SphI.
Class: Recombinant plasmid
Type: Plasmid
History of deposit: This plasmid was deposited by Dr W. Vanden Berghe(1) and Prof. Dr G. Haegeman(1).
(1) Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
Plasmid reference: Vanden Berghe et al., J. Biol. Chem. 273 (1998), 3285-3290 [PMID: 9452444]
Related plasmid reference: Vanden Berghe et al., J. Biol. Chem. 274 (1999), 32091-32098 [PMID: 10542243]
Bogard et al., Naunyn Schmiedebergs Arch. Pharmacol. 387 (2014), 329-339 [PMID: 24363043] [DOI: 10.1007/s00210-013-0950-4]
Restricted distribution: - BCCM MTA
Distributed as: H/P active culture or plasmid DNA
Host for distribution: Escherichia coli K12 MC1061
Host reference: Casadaban et al., J. Mol. Biol. 138 (1980), 179-207 [PMID: 6997493]
Related host reference: Brigé et al., Biochem. J. 394 (2006), 335-344 [PMID: 16293111]
Cultivation medium: LB-Lennox + ampicillin (100 μg/ml)
Cultivation temperature: 37°C
Biosafety level: L1
Cultivation remark: -
Other culture collection numbers: -

Note: Up-to-date, validated data are enclosed with the biological material. Nevertheless, these data are a snapshot at a given moment; further updates are always possible.

New search